Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants

This publication has 12 references indexed in Scilit:

• Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case–control study in Nepalese children 5 years after immunization
  Vaccine, 2007
• Effect of single dose of SA 14-14-2 vaccine 1 year after immunisation in Nepalese children with Japanese encephalitis: a case-control study
  The Lancet, 2005
• Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2–3 September, 2004
  Vaccine, 2005
• Vaccines administered simultaneously: directions for new combination vaccines based on an historical review of the literature
  International Journal of Infectious Diseases, 2004
• Immunogenicity of Measles and Rubella Vaccines in Oman: A Prospective Clinical Trial
  The Journal of Infectious Diseases, 2003
• NEUROLOGICAL ASPECTS OF TROPICAL DISEASE: Japanese encephalitis
  Journal of Neurology, Neurosurgery & Psychiatry, 2000
• New initiatives for the control of Japanese encephalitis by vaccination:
  Vaccine, 2000
• Effect of vitamin A supplementation on measles vaccination in nine-month-old infants
  Public Health, 1997
• Study of combined vaccination against yellow fever and measles in infants from six to nine months
  Journal of Biological Standardization, 1989
• TRIAL OF HIGH-DOSE EDMONSTON-ZAGREB MEASLES VACCINE IN THE GAMBIA: ANTIBODY RESPONSE AND SIDE-EFFECTS
  The Lancet, 1988